Term
MOA:
Block sodium and chloride retention in Loop of Henle
Decrease preload and CVP
Rapid onset, lasts 2 hours
Kidney fxn diminished--loop diuretics may still be effective |
|
Definition
|
|
Term
MOA:
Pull fluid into renal tubule, reducing cerebral edema and increasing urine production |
|
Definition
|
|
Term
INDICATIONS:
Edema r/t HF, liver failure, renal disease, HTN |
|
Definition
INDICATIONS:
Loop Diuretics |
|
|
Term
INDICATIONS:
Head trauma, early oliguric phase of renal failure
Decrease cerebral edema and ICP |
|
Definition
INDICATIONS:
Osmotic Diuretic |
|
|
Term
|
Definition
|
|
Term
IMPLICATIONS:
-Sulfonamide allergy
-Electrolyte imbalance
-Hepatic Coma
Interaxns: corticosteroids and digoxin--> hypokalemia Increased serum uric acid, glucose, AST, ALT
TOXICITY: fluid & electrolyte replacement |
|
Definition
IMPLICATIONS:
Loop Diuretics |
|
|
Term
MOA:
Vaughn Williams Classification
Class I
Class II beta blockers
Class III prolongs repolarization
Class IV calcium channel blocker |
|
Definition
|
|
Term
INDICATIONS:
V Tach
V Dys
A Fib
A Flutter |
|
Definition
INDICATIONS:
Antidysrhythmics |
|
|
Term
SE:
Antidysrhythmic hypersensitivity, n/v/d, headaches, blurred vision
Overdose: Mgmt consists of circulatory and ventilatory support; Symptomatic Treatment |
|
Definition
|
|
Term
IMPLICATIONS:
Contra: 2nd/3rd degree Heart Block, cardiogenic shock
Interaxns: Increases anticoagulant and Dilantin effects; can cause dyrhythmmmia when combined with other antidysrhythmics
Drink plenty of fluids unless contraindicated
Cardiac monitoring |
|
Definition
IMPLICATIONS:
Antidysrhythmics |
|
|
Term
MOA:
Relax vascular smooth muscle
Decrease preload=decreased O2 consumption
Dilation of coronary arteries and collaterals |
|
Definition
|
|
Term
INDICATIONS:
Angina treatment + Prophylaxis
CHF
Acute MI
Raynaud's |
|
Definition
|
|
Term
SE:
Headaches (Most common)
BradyC
Postural hypotension
dizziness
weakness
confusion
Nightmares |
|
Definition
|
|
Term
IMPLICATIONS:
Contra: Pediatrics, Geriatrics (lower doses, risk of hypotension), pregnancy, cerebral hemorrhage, impaired hepatic fxn
Caution: Viagra
Don't touch pastes/put directly over heart
Always carry SL for emergencies
Medication vacation; Avoid changing brands |
|
Definition
|
|
Term
MOA:
decrease myocardial contraxn
decrease automaticity of SA node
decrease conduction through AV node
decrease force of smooth muscle contraxn |
|
Definition
MOA:
Calcium Channel Blocker |
|
|
Term
INDICATIONS:
angina (2nd line of choice; beta blockers 1st)
HTN (best for African Americans & geriatrics)
arrhythmias |
|
Definition
INDICATIONS:
Calcium Channel Blockers |
|
|
Term
SE:
Overdose: monitor cardiac and respiratory fxn; lavage emetics; 2nd and 3rd degree heartblocks
hypotension
bradyC, asystole |
|
Definition
SE:
Calcium Channel Blockers |
|
|
Term
IMPLICATIONS:
Contra: Hypersensitivity, Sick Sinus Syndrome, Heart Blocks, Lactation |
|
Definition
IMPLICATIONS:
Calcium Channel Blocker |
|
|
Term
MOA:
Adrenergic: Block SNS stimulation (beta 1 cardioselective, beta 2 nonselective)
Compete with natural epi and norepi, blocking SNS stimulation of receptor sites
Decrease HR, conduction, and contractility |
|
Definition
|
|
Term
INDICATIONS:
Angina (1st choice)
Inhibit catecholamines
Post MI
dysrhythmias
HTN (Caucasians)
Migraine Head Ache |
|
Definition
INDICATIONS:
Adrenergic Blockers |
|
|
Term
SE:
Extended actions
acute withrdawal w/c exacerbates angina and precipitates MI
MASK SIGNS OF HYPOGLYCEMIA |
|
Definition
SE:
Adrenergic Blockers
Beta Blockers |
|
|
Term
IMPLICATIONS:
Contra: uncompensated HF, cardiogenic shock, Heart block, bradyC, pregnancy, severe pulmonary disease, Raynaud's
Taper Medication, monitor pulse
Diabetic pts (signs and symptoms of hypoglycemia)
Avoid OTC sympathomimetics
Causes impotence in male pts |
|
Definition
IMPLICATION:
Adrenergic Blockers
Beta blockers |
|
|
Term
MOA:
Suppress RAAS
Reduce SVR, lowering BP
no change in HR
Increases renal perfusion |
|
Definition
|
|
Term
INDICATIONS:
HTN + thiazide diuretic
CHF
MI
Diabetic neuropathy
L Ventricular Dysfunction |
|
Definition
INDICATIONS:
ACE Inhibitors |
|
|
Term
SE:
hypotension
palpitations
angina
orhtostatic hypotension
chronic cough (predominant SE) |
|
Definition
|
|
Term
IMPLICATIONS:
Contra: Hx angioedema, 2nd and 3rd trimester of pregnancy, renal insufficiency, geriatrics
Identify name, type, and dose of drug for pt
DO NOT double dose
Identify common SE
Take with or without food |
|
Definition
IMPLICATIONS:
ACE inhibitors |
|
|
Term
MOA:
increase muscle contractility
decrease conduction
inotropic, chronotropics, dromotropic effects |
|
Definition
|
|
Term
INDICATIONS:
HF
Supraventricular Dysrhythmias
Promote Diuresis |
|
Definition
INDICATIONS:
Cardiac Glycosides |
|
|
Term
IMPLICATIONS:
Contra: 2nd/3rd degree heart block, V Tach, V Fib
DO NOT DOUBLE DOSE
DO NOT switch b/w trades and generics
DO NOT increase salt intake
KEEP OUT OF REACH of pets and children
wear ID bracelet |
|
Definition
IMPLICATIONS:
Cardiac Glycosides |
|
|
Term
MOA:
Deplete norepi storage in neurotransmitter storage vesicles so that SNS is NOT stimulated
Result: decreased BP |
|
Definition
MOA:
Adrenergic Agents
Central and Peripheral Acting Neuron Blocker |
|
|
Term
INDICATIONS:
HTN treatment
(seldom used because of frequent SE) |
|
Definition
INDICATIONS:
Adrenergic Agent
Central and Peripheral Acting Neuron Blocker |
|
|
Term
SE:
Dry mouth, drowsiness, sedation, constipation
Headaches, sleep disturbances, nausea, rash, palpitations
Orthostatic hypotension |
|
Definition
SE:
Adrenergic Agent
Central and Peripheral Acting Neuron Blocker |
|
|
Term
MOA:
Stimulate alpha-2 receptors in brain, decreasing sympathetic outflow from CNS in the brain
(decrease epi and norepi)
Result: decreased BP because of increased stimulus to alpha-2 receptors inhibits the further release of NE
END RESULT: VASODILATION |
|
Definition
MOA:
Adrenergic Agent
Central Alpha-2 Agonists |
|
|
Term
INDICATIONS:
Tx of HTN, usually after other agents have failed due to side effects
Tx Dysmenorrhea, menopausal flushing, glaucoma
Clonidine: mgmt of w/drawal symptoms in opioid or nicotine dependent persons |
|
Definition
INDICATIONS:
Adrenergic Agents
Central Alpha-2 Agonists |
|
|
Term
IMPLICATIONS:
HTN drug of choice for PREGNANCY |
|
Definition
IMPLICATIONS:
Adrenergic Agents
Central Alpha-2 Agonists |
|
|
Term
MOA:
Block alpha-1 so SNS is not stimulated
RESULT: decreased BP |
|
Definition
MOA:
Adrenergic Agent
Peripheral Alpha-1 antagonist |
|
|
Term
INDICATIONS:
Tx HTN
Relief of Sx, of BPH
Mgmt of severe HF + caridiac glycosides and diuretics |
|
Definition
INDICATIONS:
Adrenergic Agents
Peripheral Alpha-1 Antagonists |
|
|
Term
MOA:
Act in periphery of heart and blood vessels
Decrease HR (beta-1 blockade)
Cause vasodilation (Alpha-1 blockade) |
|
Definition
MOA:
Adrenergic Agent
Dual Alpha 1 and Beta Blocker |
|
|
Term
MOA:
Act in periphery of heart to decrease HR |
|
Definition
MOA:
Adrenergic Agent
Beta Blocker |
|
|
Term
MOA:
Block ACE, thus preventing formation of angiotensin II
Prevent breakdown of bradykinin
Result: Decreased systemic vascular resistance (afterload); vasodilation, DECREASED BP |
|
Definition
|
|
Term
INDICATIONS:
HTN
HF
Slow down L. Vent Hypertrophy post MI
Renal protection in diabetic pts |
|
Definition
INDICATIONS:
ACE Inhibitors |
|
|
Term
SE:
Fatigue, headache, impaired taste, dizziness, mood changes, hyperkalemia
Dry, nonproductive cough which reverses when therapy is discontinued |
|
Definition
|
|
Term
IMPLICATIONS:
First-dose hypotension may occur
Pt K+>5.0 mEq NOT suitable for use, can potentiate
LITHIUM TOXICITY |
|
Definition
IMPLICATIONS:
ACE Inhibitors |
|
|
Term
MOA:
Allow angiotensin I to convert to angiotensin II, but BLOCKS receptors that rcv angiotensin II
Blocks vasoconstriction and release of aldosterone |
|
Definition
|
|
Term
INDICATIONS:
HTN, Adjunct in HF
May be used alone or with other agent as diuretics
Primarily used in pts who cannot tolerate ACE inhibitos |
|
Definition
|
|
Term
SE:
URI
Headaches
Dizziness, Insomnia, Diarrhea, Dyspnea, heartburn, nasal congestion, back pain, fatigue
Hyperkalemia less likely to occur |
|
Definition
|
|
Term
IMPLICATIONS:
Well tolerated because does not cause cough like ACE inhibitors |
|
Definition
|
|
Term
MOA:
Causes sm muscle relaxation by blocking calcium binding
Decreased peripheral smooth muscle tone and decreased systemic vascular resistance
RESULT: Decreased BP |
|
Definition
MOA:
Calcium Channel Blocker |
|
|
Term
INDICATIONS:
Angina
HTN
Dyrhythmias
Migraine Headaches
Raynaud's |
|
Definition
INDICATIONS:
Calcium Channel Blockers |
|
|
Term
SE:
hypotension, palpitations, tachC, constipation, nausea, rash flushing, peripheral edema, dermatitis |
|
Definition
SE:
Calcium Channel Blockers |
|
|
Term
MOA:
Directly relaxes arteriolar smooth muscle
Result: decreased systemic vascular response, decreased afterload, peripheral vasodilation |
|
Definition
|
|
Term
INDICATIONS:
HTN
Emergency HTN: Sodium nitroprusside Diazoxide |
|
Definition
INDICATIONS:
Vasodilators |
|
|
Term
SE:
Hydralazine: Dizziness, Headaches, tachC, n/v, diarrhea, anemia, dyspnea, edema, nasal congestion
Sodium Nitroprusside: bradyC, hypotension,
CYANIDE TOXICITY |
|
Definition
|
|